Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

A single nucleotide polymorphism in the 3'UTR of the SNCA gene encoding alpha-synuclein is a new potential susceptibility locus for Parkinson disease.

Sotiriou S, Gibney G, Baxevanis AD, Nussbaum RL.

Neurosci Lett. 2009 Sep 18;461(2):196-201. doi: 10.1016/j.neulet.2009.06.034.

2.

Variants in the 3'UTR of SNCA do not affect miRNA-433 binding and alpha-synuclein expression.

Schmitt I, Wüllner U, van Rooyen JP, Khazneh H, Becker J, Volk A, Kubisch C, Becker T, Kostic VS, Klein C, Ramirez A.

Eur J Hum Genet. 2012 Dec;20(12):1265-9. doi: 10.1038/ejhg.2012.84.

3.

Lack of replication of a previously reported association between polymorphism in the 3'UTR of the alpha-synuclein gene and Parkinson's disease in Chinese subjects.

Hu FY, Hu WB, Liu L, Yu LH, Xi J, He XH, Zhu MR, Liu ZL, Xu YM.

Neurosci Lett. 2010 Jul 19;479(1):31-3. doi: 10.1016/j.neulet.2010.05.022.

PMID:
20478361
4.

alpha-Synuclein and Parkinson disease susceptibility.

Winkler S, Hagenah J, Lincoln S, Heckman M, Haugarvoll K, Lohmann-Hedrich K, Kostic V, Farrer M, Klein C.

Neurology. 2007 Oct 30;69(18):1745-50.

PMID:
17872362
5.
6.

Familial genes in sporadic disease: common variants of alpha-synuclein gene associate with Parkinson's disease.

Ross OA, Gosal D, Stone JT, Lincoln SJ, Heckman MG, Irvine GB, Johnston JA, Gibson JM, Farrer MJ, Lynch T.

Mech Ageing Dev. 2007 May-Jun;128(5-6):378-82.

7.

Analysis of polymorphisms in the 3' untranslated region of the LDL receptor gene and their effect on plasma cholesterol levels and drug response.

Chen W, Wang S, Ma Y, Zhou Y, Liu H, Strnad P, Kraemer FB, Krauss RM, Liu J.

Int J Mol Med. 2008 Mar;21(3):345-53.

PMID:
18288382
8.

SNCA and MAPT genes: Independent and joint effects in Parkinson disease in the Italian population.

Trotta L, Guella I, Soldà G, Sironi F, Tesei S, Canesi M, Pezzoli G, Goldwurm S, Duga S, Asselta R.

Parkinsonism Relat Disord. 2012 Mar;18(3):257-62. doi: 10.1016/j.parkreldis.2011.10.014.

9.

SNCA variant associated with Parkinson disease and plasma alpha-synuclein level.

Mata IF, Shi M, Agarwal P, Chung KA, Edwards KL, Factor SA, Galasko DR, Ginghina C, Griffith A, Higgins DS, Kay DM, Kim H, Leverenz JB, Quinn JF, Roberts JW, Samii A, Snapinn KW, Tsuang DW, Yearout D, Zhang J, Payami H, Zabetian CP.

Arch Neurol. 2010 Nov;67(11):1350-6. doi: 10.1001/archneurol.2010.279.

10.

The effect of SNCA 3' region on the levels of SNCA-112 splicing variant.

McCarthy JJ, Linnertz C, Saucier L, Burke JR, Hulette CM, Welsh-Bohmer KA, Chiba-Falek O.

Neurogenetics. 2011 Feb;12(1):59-64. doi: 10.1007/s10048-010-0263-4.

11.

Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson's disease.

Mizuta I, Satake W, Nakabayashi Y, Ito C, Suzuki S, Momose Y, Nagai Y, Oka A, Inoko H, Fukae J, Saito Y, Sawabe M, Murayama S, Yamamoto M, Hattori N, Murata M, Toda T.

Hum Mol Genet. 2006 Apr 1;15(7):1151-8.

12.

YY1 binds to α-synuclein 3'-flanking region SNP and stimulates antisense noncoding RNA expression.

Mizuta I, Takafuji K, Ando Y, Satake W, Kanagawa M, Kobayashi K, Nagamori S, Shinohara T, Ito C, Yamamoto M, Hattori N, Murata M, Kanai Y, Murayama S, Nakagawa M, Toda T.

J Hum Genet. 2013 Nov;58(11):711-9. doi: 10.1038/jhg.2013.90.

PMID:
24026176
13.
14.

[SNCA rs356219 AND rs356165 VARIANTS ARE ASSOCIATED WITH PARKINSON'S DISEASE AND INCREASED ALPHA-SYNUCLEIN GENE EXPRESSION IN THE CD45(+)-BLOOD CELLS].

Emelyanov AK, Andoskin PA, Miliukhina IV, Timofeeva AA, Yakimovskii AF, Senkevich KA, Nikolaev MA, Pchelina SN.

Tsitologiia. 2016;58(2):99-104. Russian.

PMID:
27228655
15.

Genetic Variants of SNCA Are Associated with Susceptibility to Parkinson's Disease but Not Amyotrophic Lateral Sclerosis or Multiple System Atrophy in a Chinese Population.

Chen Y, Wei QQ, Ou R, Cao B, Chen X, Zhao B, Guo X, Yang Y, Chen K, Wu Y, Song W, Shang HF.

PLoS One. 2015 Jul 24;10(7):e0133776. doi: 10.1371/journal.pone.0133776.

16.

SNP rs356219 of the α-synuclein (SNCA) gene is associated with Parkinson's disease in a Chinese Han population.

Pan F, Dong H, Ding H, Ye M, Liu W, Wu Y, Zhang X, Chen Z, Luo Y, Ding X.

Parkinsonism Relat Disord. 2012 Jun;18(5):632-4. doi: 10.1016/j.parkreldis.2012.01.025.

PMID:
22349157
17.

A systematic analysis of the 3'UTR of HNF4A mRNA reveals an interplay of regulatory elements including miRNA target sites.

Wirsing A, Senkel S, Klein-Hitpass L, Ryffel GU.

PLoS One. 2011;6(11):e27438. doi: 10.1371/journal.pone.0027438.

18.

Alpha-synuclein (SNCA) polymorphisms and susceptibility to Parkinson's disease: a meta-analysis.

Han W, Liu Y, Mi Y, Zhao J, Liu D, Tian Q.

Am J Med Genet B Neuropsychiatr Genet. 2015 Mar;168B(2):123-34. doi: 10.1002/ajmg.b.32288.

PMID:
25656566
19.

Expansion of the Parkinson disease-associated SNCA-Rep1 allele upregulates human alpha-synuclein in transgenic mouse brain.

Cronin KD, Ge D, Manninger P, Linnertz C, Rossoshek A, Orrison BM, Bernard DJ, El-Agnaf OM, Schlossmacher MG, Nussbaum RL, Chiba-Falek O.

Hum Mol Genet. 2009 Sep 1;18(17):3274-85. doi: 10.1093/hmg/ddp265.

20.

Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease.

Maraganore DM, de Andrade M, Elbaz A, Farrer MJ, Ioannidis JP, Krüger R, Rocca WA, Schneider NK, Lesnick TG, Lincoln SJ, Hulihan MM, Aasly JO, Ashizawa T, Chartier-Harlin MC, Checkoway H, Ferrarese C, Hadjigeorgiou G, Hattori N, Kawakami H, Lambert JC, Lynch T, Mellick GD, Papapetropoulos S, Parsian A, Quattrone A, Riess O, Tan EK, Van Broeckhoven C; Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium..

JAMA. 2006 Aug 9;296(6):661-70.

PMID:
16896109
Items per page

Supplemental Content

Support Center